Ürək-damar cərrahiyyəsi

  https://www.aic.cuhk.edu.hk/web8/antiarhythmics.htm#lignocainePharmacology and Therapeutics for Dentistry. John A. Yagiela,Frank J. Dowd,Bart Johnson,Angelo Mariotti,Enid A. Neidle. 2010.

  Ədəbiyyat verilməyib

  Yetman AT, Rosenberg HC, Joubert GI. Progression of asymptomatic aortic stenosis identified in the neonatal period. Am J Cardiol. 1995 Mar 15. 75(8):636-7. para, childcount:2Ten Harkel AD, Berkhout M, Hop WC, Witsenburg M, Helbing WA. Congenital valvular aortic stenosis: limited progression during childhood. Arch Dis Child. 2009 Jul. 94(7):531-5.para, childcount:2Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005 Apr 19. 45(8):1318-21. para, childcount:2Fratz S, Gildein HP, Balling G, et al. Aortic valvuloplasty in pediatric patients substantially postpones the need for aortic valve surgery: a single-center experience of 188 patients after up to 17.5 years of follow-up. Circulation. 2008 Mar 4. 117(9):1201-6. para, childcount:2Egito ES, Moore P, O'Sullivan J, et al. Transvascular balloon dilation for neonatal critical aortic stenosis: early and midterm results. J Am Coll Cardiol. 1997 Feb. 29(2):442-7.

  Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. para, childcount:2Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. para, childcount:2Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. para, childcount:2Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. para, childcount:2Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. para, childcount:2Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82.

  Rudolph AM, Heymann MA, Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol. 1972 Oct. 30(5):514-25. Talner NS, Berman MA. Postnatal development of obstruction in coarctation of the aorta: role of the ductus arteriosus. Pediatrics. 1975 Oct. 56(4):562-9.Gersony WM. Coarctation of the aorta. Adams FH, Emmanouildes GC, Riemenschneider TA, eds. Moss' Heart Disease in Infants, Children and Adolescents. 4th ed. Baltimore, MD: Williams & Wilkins; 1989. 243-55.

  Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. para, childcount:2Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. para, childcount:2Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. para, childcount:2Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. para, childcount:2Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. para, childcount:2Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82.

  Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. para, childcount:2Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. para, childcount:2Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. para, childcount:2Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. para, childcount:2Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. para, childcount:2Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82.

  Ədəbiyyat verilməyib

  Karmiloff-Smith A, Al-Janabi T, D'Souza H, et al. The importance of understanding individual differences in Down syndrome. F1000Res. 2016. 5:Lejeune J. Le mongolisme. Premier example d'aberration autosomique humaine. Ann Genet. 1959. 1:41-9. Jacobs PA, Baikie AG, Court Brown WM, Strong JA. The somatic chromosomes in mongolism. Lancet. 1959 Apr 4. 1(7075):710. Peterson MB, Mikkelsen M. Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet. 2000. 91:199-203. Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995 Feb. 33(1):54-6. LEJEUNE J, GAUTIER M, TURPIN R. [Study of somatic chromosomes from 9 mongoloid children]. C R Hebd Seances Acad Sci. 1959 Mar 16. 248(11):1721-2. Levenson D. Talking about Down syndrome. Am J Med Genet A. 2009 Feb 15. 149A(4):vii-viii.. [Guideline] Hartway S. A parent's guide to the genetics of Down syndrome. Adv Neonatal Care. 2009 Feb. 9(1):27-30.

  Ədəbiyyat verilməyib

  [Guideline] Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007 Jun 12. 115(23):2995-3014.Kutty S, Hazeem AA, Brown K, Danford CJ, Worley SE, Delaney JW, et al. Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol. 2012 May 1. 109(9):1348-52. [Medline]. Fukazawa M, Fukushige J, Ueda K. Atrial septal defects in neonates with reference to spontaneous closure. Am Heart J. 1988 Jul. 116(1 Pt 1):123-7.Putra ST, Djer MM, Idris NS, Samion H, Sastroasmoro S. Transcatheter closure of atrial septal defects in a center with limited resources: outcomes and short term follow-up. Iran J Pediatr. 2015 Dec. 25(6):e3906. Kutty S, Hazeem AA, Brown K, et al. Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol. 2012 May 1. 109(9):1348-52.

  Rahman A, Isenberg D A. Systemic lupus erythematosus. N Engl J Med. 2008;358:929-39.Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61:1065–70. Ledford DK. Immunologic aspects of vasculitis and cardiovascular disease. JAMA. 1997;278:1962–71. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti- phospholipid syndrome and neonatal lupus. Rheumatology. 2006;45:8–13. Buyon JP, Waltock J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus. 1995;4:116-21. Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody- associated congenital heart block in neonatal lupus. Curr Rheumatol Rep. 2007;9:101–8.

  Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. para, childcount:2Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. para, childcount:2Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. para, childcount:2Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. para, childcount:2Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. para, childcount:2Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82.

  Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007 Jul. 92(4):F244-7. Attridge JT, Kaufman DA, Lim DS. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2009 May. 94(3):F178-82. Nuntnarumit P, Chongkongkiat P, Khositseth A. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants. Acta Paediatr. 2011 Sep. 100(9):1217-21. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2008 Jan 23. CD003481. Sekar KC, Corff KE. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?. J Perinatol. 2008 May. 28 Suppl 1:S60-2. Takami T, Yoda H, Kawakami T, et al. Usefulness of indomethacin for patent ductus arteriosus in full-term infants. Pediatr Cardiol. 2007 Jan-Feb. 28(1):46-50.

  Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007 Jul. 92(4):F244-7. Attridge JT, Kaufman DA, Lim DS. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2009 May. 94(3):F178-82. Nuntnarumit P, Chongkongkiat P, Khositseth A. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants. Acta Paediatr. 2011 Sep. 100(9):1217-21. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2008 Jan 23. CD003481. Sekar KC, Corff KE. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?. J Perinatol. 2008 May. 28 Suppl 1:S60-2. Takami T, Yoda H, Kawakami T, et al. Usefulness of indomethacin for patent ductus arteriosus in full-term infants. Pediatr Cardiol. 2007 Jan-Feb. 28(1):46-50.

  Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed. 2008;93:F33–F35.Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978;42:641. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–e171.Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child. 1994;71:3–7. Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol. 2001;28:91–136. Pickert CB, Moss MM, Fiser DH. Differentiation of systemic infection and congenital obstructive left heart disease in the very young infant. Pediatr Emerg Care. 1998;14:263–267. Karimova A, Brown K, Ridout D, Beierlein W, Cassidy J, Smith J, et al. Neonatal extracorporeal membrane oxygenation: practice patterns and predictors of outcome in the UK. Arch Dis Child Fetal Neonatal Ed. 2009;94:F129–F132.

  Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005 Nov-Dec. 25(6):1535-46. para, childcount:2Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). 2008 Jul-Aug. 84(4):377-80. para, childcount:2Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 2005 Feb. 15 Suppl 1:38-47. para, childcount:2Marinho C, Alho I, Guerra A, Rego C, Areias J, Bicho M. The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of Fallot. Rev Port Cardiol. 2009 Jul-Aug. 28(7-8):809-12. para, childcount:2Lee CN, Su YN, Cheng WF, et al. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. 2005 Dec. 84(12):1134-40. para, childcount:2Li X, Liu CL, Li XX, Li QC, Ma LM, Liu GL. VEGF gene polymorphisms are associated with risk of tetralogy of Fallot. Med Sci Monit. 2015 Nov 12. 21:3474-82.

  Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287:1308–1320.Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 1995; 92:785–789.Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064–1075.Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published online ahead of print November 8, 2011]. J Am Coll Cardiol 2011; 58:e212–e260. doi:10.1016/j.jacc.2011.06.011.Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001; 33:655–670.Elliot P, Baker R, Pasquale F, et al. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey [published online ahead of print September 2, 2011]. Heart 2011; 97:1957–1960. doi:10.1136/heartjnl-2011-300364.Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352:362–372.Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54:201–211.Maron BJ, Maron MS. Hypertrophic cardiomyopathy [published online ahead of print August 6, 2012]. Lancet 2013; 381:242–255. doi:10.1016/S0140-6736(12)60397-3.

  Ahmed MI, McGiffin DC, O'Rourke RA, Dell'Italia LJ. Mitral regurgitation. Curr Probl Cardiol. 2009 Mar. 34(3):93-136. Rahimtoola SH. The mitral valve is a complex structure. Foreword. Curr Probl Cardiol. 2009 Mar. 34(3):89. Kalfa D, Vergnat M, Ly M, et al. A standardized repair-oriented strategy for mitral insufficiency in infants and children: midterm functional outcomes and predictors of adverse events. J Thorac Cardiovasc Surg. 2014 Oct. 148(4):1459-66. Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. 2009 Apr. 157(4):762.e3-10. Pederzolli N, Agostini F, Fiorani V, et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med (Hagerstown). 2009 Mar. 10(3):259-60. Carpentier A. Congenital malformations of the mitral valve. Stark J, de Laval M, eds. Surgery for Congenital Heart Defects. WB Saunders Co; 1983. 467-82.

  Ədəbiyyat verilməyib